Patent | Date |
---|
Crystalline Form Of A Dihydrochloride Salt Of A Jak Inhibitor Compound App 20220306626 - Nzerem; Jerry ;   et al. | 2022-09-29 |
Jak Kinase Inhibitor Compounds For Treatment Of Respiratory Disease App 20220306624 - Fatheree; Paul R. ;   et al. | 2022-09-29 |
Combination dosage form of a mu opioid receptor antagonist and an opioid agent Grant 11,452,723 - Li , et al. September 27, 2 | 2022-09-27 |
Crystalline (2s,4r)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(- 3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic Acid And Uses Thereof App 20220242836 - Hughes; Adam D. ;   et al. | 2022-08-04 |
Pyrazolo And Triazolo Bicyclic Compounds As Jak Kinase Inhibitors App 20220119369 - McKinnell; Robert Murray ;   et al. | 2022-04-21 |
Formulation Of A Pan-jak Inhibitor App 20220112220 - Nitert; Bernardus Joseph ;   et al. | 2022-04-14 |
Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(- 3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof Grant 11,230,536 - Hughes , et al. January 25, 2 | 2022-01-25 |
(2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic Acid App 20210401808 - Fleury; Melissa ;   et al. | 2021-12-30 |
Methods of treatment using a JAK inhibitor compound Grant 11,160,800 - Thalladi , et al. November 2, 2 | 2021-11-02 |
Fused imidazo-piperidine JAK inhibitor compound Grant 11,160,810 - McKinnell , et al. November 2, 2 | 2021-11-02 |
Naphthyridine Compounds As Jak Kinase Inhibitors App 20210179637 - Hudson; Ryan ;   et al. | 2021-06-17 |
(2R,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic acid Grant 11,033,533 - Fleury , et al. June 15, 2 | 2021-06-15 |
Combination Dosage Form Of A Mu Opioid Receptor Antagonist And An Opioid Agent App 20210161884 - Li; Shaoling ;   et al. | 2021-06-03 |
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors Grant 10,968,205 - McKinnell , et al. April 6, 2 | 2021-04-06 |
Combination dosage form of a mu opioid receptor antagonist and an opioid agent Grant 10,946,009 - Li , et al. March 16, 2 | 2021-03-16 |
Methods for treating ulcerative colitis using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-- yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile Grant 10,947,254 - Hudson , et al. March 16, 2 | 2021-03-16 |
Crystalline (2s,4r)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(- 3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic Acid And Uses Thereof App 20210061776 - Hughes; Adam D. ;   et al. | 2021-03-04 |
JAK kinase inhibitor compounds for treatment of respiratory disease Grant 10,913,740 - Fatheree , et al. February 9, 2 | 2021-02-09 |
(2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic Acid App 20200281900 - Fleury; Melissa ;   et al. | 2020-09-10 |
Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(- 3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof Grant 10,752,599 - Hughes , et al. A | 2020-08-25 |
Pyrazolo And Triazolo Bicyclic Compounds As Jak Kinase Inhibitors App 20200216423 - MCKINNELL; ROBERT MURRAY ;   et al. | 2020-07-09 |
Crystalline (2s,4r)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(- 3-hydroxyisoxazole-5-carboxamido)-2-methy App 20200157061 - Hughes; Adam D. ;   et al. | 2020-05-21 |
Methods Of Treatment Using A Jak Inhibitor Compound App 20200121669 - THALLADI; VENKAT R. ;   et al. | 2020-04-23 |
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease App 20200087303 - Fatheree; Paul R. ;   et al. | 2020-03-19 |
Fused Imidazo-piperidine Jak Inhibitor Compound App 20200046719 - MCKINNELL; ROBERT MURRAY ;   et al. | 2020-02-13 |
Naphthyridine Compounds As Jak Kinase Inhibitors App 20200040010 - Hudson; Ryan ;   et al. | 2020-02-06 |
(2R,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic acid Grant 10,548,879 - Fleury , et al. Fe | 2020-02-04 |
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors Grant 10,538,513 - McKinnell , et al. Ja | 2020-01-21 |
Fused imidazo-piperidine JAK inhibitor compound Grant 10,493,077 - Fatheree , et al. De | 2019-12-03 |
Crystalline solvate comprising 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-- yl)amino-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile, methanol, N-N-dimethylformamide, and water Grant 10,494,382 - Huang , et al. De | 2019-12-03 |
Crystalline(2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-bipheny]-4-yl)-2-(ethoxyme- thyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof Grant 10,472,335 - Hughes , et al. Nov | 2019-11-12 |
Combination Dosage Form Of A Mu Opioid Receptor Antagonist And An Opioid Agent App 20190321350 - Li; Shaoling ;   et al. | 2019-10-24 |
Pyrazolo And Triazolo Bicyclic Compounds As Jak Kinase Inhibitors App 20190315724 - MCKINNELL; ROBERT MURRAY ;   et al. | 2019-10-17 |
(2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic Acid App 20190269659 - Fleury; Melissa ;   et al. | 2019-09-05 |
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors Grant 10,392,368 - Fenster , et al. A | 2019-08-27 |
Combination dosage form of a mu opioid receptor antagonist and an opioid agent Grant 10,369,142 - Li , et al. | 2019-08-06 |
Crystalline forms of a JAK inhibitor compound Grant 10,251,874 - Dabros , et al. | 2019-04-09 |
Pyrazolo And Triazolo Bicyclic Compounds As Jak Kinase Inhibitors App 20190040043 - FENSTER; ERIK ;   et al. | 2019-02-07 |
JAK kinase inhibitor compounds for treatment of respiratory disease Grant 10,183,942 - Benjamin , et al. Ja | 2019-01-22 |
(2R,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic acid Grant 10,172,834 - Fleury , et al. J | 2019-01-08 |
Crystalline(2s,4r)-5-(5'-chloro-2'-fluoro-[1,1'-bipheny]-4-yl)-2-(ethoxyme- Thyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic Acid And Uses Thereof App 20190002416 - Hughes; Adam D. ;   et al. | 2019-01-03 |
Naphthyridine Compounds As Jak Kinase Inhibitors App 20180354974 - Huang; Xiaojun ;   et al. | 2018-12-13 |
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease App 20180319796 - Benjamin; Noah ;   et al. | 2018-11-08 |
Crystalline Forms Of A Jak Inhibitor Compound App 20180311223 - DABROS; MARTA ;   et al. | 2018-11-01 |
Fused Imidazo-piperidine Jak Inhibitor Compound App 20180311255 - FATHEREE; PAUL R. ;   et al. | 2018-11-01 |
Methods Of Treatment Using A Jak Inhibitor Compound App 20180311226 - THALLADI; Venkat R. ;   et al. | 2018-11-01 |
Crystalline(2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxym- ethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof Grant 10,100,021 - Hughes , et al. October 16, 2 | 2018-10-16 |
Crystalline form of 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-- yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile Grant 10,072,026 - Huang , et al. September 11, 2 | 2018-09-11 |
(2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic Acid App 20180228774 - Fleury; Melissa ;   et al. | 2018-08-16 |
Combination Dosage Form Of A Mu Opioid Receptor Antagonist And An Opioid Agent App 20180050028 - Li; Shaoling ;   et al. | 2018-02-22 |
(2R,4R)-5-(5'-Chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic acid Grant 9,872,855 - Fleury , et al. January 23, 2 | 2018-01-23 |
(2S,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- xymethyl-2-methylpentanoic acid Grant 9,868,698 - Hughes , et al. January 16, 2 | 2018-01-16 |
(2s,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- Xymethyl-2-methylpentanoic Acid App 20170355665 - Hughes; Adam D. ;   et al. | 2017-12-14 |
Naphthyridine Compounds As Jak Kinase Inhibitors App 20170305934 - Huang; Xiaojun ;   et al. | 2017-10-26 |
Crystalline(2s,4r)-5-(5'-chloro-2'-fluoro-[1,1'-bipheny]-4-yl)-2-(ethoxyme- Thyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic Acid And Uses Thereof App 20170275259 - Hughes; Adam D. ;   et al. | 2017-09-28 |
(2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic Acid App 20170196841 - Fleury; Melissa ;   et al. | 2017-07-13 |
(2S,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- xmethyl-2-methylpentanoic acid Grant 9,670,143 - Hughes , et al. June 6, 2 | 2017-06-06 |
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease App 20170121327 - Fatheree; Paul R. ;   et al. | 2017-05-04 |
(2s,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- Xymethyl-2-methylpentanoic Acid App 20170088508 - Hughes; Adam D. ;   et al. | 2017-03-30 |
(2R,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic acid Grant 9,533,962 - Fleury , et al. January 3, 2 | 2017-01-03 |
Naphthyridine Compounds As Jak Kinase Inhibitors App 20160347772 - Hudson; Ryan ;   et al. | 2016-12-01 |
Combination Dosage Form Of A Mu Opioid Receptor Antagonist And An Opioid Agent App 20160287573 - Li; Shaoling ;   et al. | 2016-10-06 |
(2S,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- xymethyl-2-methylpentanoic acid Grant 9,433,598 - Hughes , et al. September 6, 2 | 2016-09-06 |
(2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic Acid App 20160244416 - Fleury; Melissa ;   et al. | 2016-08-25 |
(2s,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- Xymethyl-2-methylpentanoic Acid App 20160228395 - Hughes; Adam D. ;   et al. | 2016-08-11 |
Crystalline forms of (R)-3-[N-(3'-chlorobiphenyl-4-ylmethyl)-N'-(3-hydroxyisoxazole-5-carbonyl- )hydrazino]-2-hydroxyproprionic acid isopropyl ester Grant 9,271,965 - Thalladi , et al. March 1, 2 | 2016-03-01 |
Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid Grant 9,249,105 - Fatheree , et al. February 2, 2 | 2016-02-02 |
Crystalline Forms Of A 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine Compound App 20150141483 - Colson; Pierre-Jean ;   et al. | 2015-05-21 |
Crystalline Forms Of An Alkoxyimidazol-1-ylmethyl Biphenyl Carboxylic Acid App 20150133518 - Fatheree; Paul R. ;   et al. | 2015-05-14 |
Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound Grant 8,969,403 - Colson , et al. March 3, 2 | 2015-03-03 |
Crystalline form of a pyridyl-piperazinyl hepatitis C virus inhibitor Grant 8,883,135 - Thalladi , et al. November 11, 2 | 2014-11-11 |
Levodopa prodrug mesylate hydrate Grant 8,722,733 - Karaborni , et al. May 13, 2 | 2014-05-13 |
Crystalline Forms Of A 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine Compound App 20140121385 - Colson; Pierre-Jean ;   et al. | 2014-05-01 |
Crystalline oxalate salts of a diamide compound Grant 8,697,724 - Rapta , et al. April 15, 2 | 2014-04-15 |
Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound Grant 8,658,691 - Colson , et al. February 25, 2 | 2014-02-25 |
Crystalline Form Of A Pyridyl-piperazinyl Hepatitis C Virus Inhibitor App 20130295048 - Thalladi; Venkat R. ;   et al. | 2013-11-07 |
Crystalline Forms Of (r)-3-[n-(3'-chlorobiphenyl-4-ylmethyl)-n'-(3-hydroxyisoxazole-5-carbonyl- )hydrazino]-2-hydroxypropionic Acid Isopropyl Ester App 20130259897 - Thalladi; Venkat R. ;   et al. | 2013-10-03 |
Crystalline Forms Of A 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine Compound App 20130085172 - COLSON; Pierre-Jean ;   et al. | 2013-04-04 |
Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid Grant 8,362,060 - Fatheree , et al. January 29, 2 | 2013-01-29 |
Crystalline Forms Of An Alkoxyimidazol-1-ylmethyl Biphenyl Carboxylic Acid App 20120115920 - FATHEREE; Paul R. ;   et al. | 2012-05-10 |
Multi-transduction mechanism based microfluidic analyte sensors Grant 7,935,309 - McGimpsey , et al. May 3, 2 | 2011-05-03 |
Selective Growth Of Stable Polymorphs App 20110009623 - Cox; Jason R. ;   et al. | 2011-01-13 |
Levodopa Prodrug Mesylate Hydrate App 20100099761 - Karaborni; Sami ;   et al. | 2010-04-22 |
Multi-transduction mechanism based microfluidic analyte sensors App 20070042450 - McGimpsey; W. Grant ;   et al. | 2007-02-22 |